Nalls Sherbakoff Group, LLC Merck & Co., Inc. Transaction History
Nalls Sherbakoff Group, LLC
- $112 Billion
- Q4 2023
A detailed history of Nalls Sherbakoff Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nalls Sherbakoff Group, LLC holds 1,673 shares of MRK stock, worth $190,203. This represents 0.16% of its overall portfolio holdings.
Number of Shares
1,673
Previous 1,689
0.95%
Holding current value
$190,203
Previous $174 Million
4.89%
% of portfolio
0.16%
Previous 0.17%
Shares
5 transactions
Others Institutions Holding MRK
# of Institutions
3,830Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$27.8 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$23.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$13.4 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$8.24 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.48 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $288B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...